Study of HRS-8797 in healthy volunteers
Part of Genetic & congenital, Immune system & allergy, Skin clinical trials.
This trial tests a new medicine called HRS-8797 in healthy people. It helps researchers understand how the drug works and if it is safe before testing in patients.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 55 years old.
- You are in good overall health with no serious medical conditions.
- Your weight is at least 110 pounds (for men) or 99 pounds (for women), and your body mass index is between 18 and 28.
- If you or your partner can become pregnant, you agree to use effective birth control during the study and for 4 weeks after the last dose.
- You have not donated blood or had a major injury or surgery in the last 3 months.
- You do not smoke more than 5 cigarettes a day and can avoid smoking during the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This is an early-stage safety study testing a new experimental drug called HXN5003 in healthy volunteers. Researchers will give increasing doses to see how safe the drug is and how the body handles it.
This early-stage trial tests a new experimental medicine called REGN20423 in two groups: healthy volunteers and people with atopic dermatitis (a chronic skin condition causing itching and inflammation). The trial aims to assess whether the medicine is safe and well-tolerated.
This trial tests a new medicine called BBT001, first in healthy people and then in adults with moderate to severe eczema (atopic dermatitis). It aims to see if the drug is safe and how well it works for treating eczema that hasn't improved with topical treatments.
This is an early-stage safety study of an experimental drug called HRS-7156 in people with no serious health conditions. Researchers will monitor how your body tolerates the drug and how it moves through your system.
This trial tests an experimental drug called HRS-3095 in healthy people to check its safety and how the body handles it. It may help find the right dose for future studies.
This trial tests an investigational drug called TRB-061 in healthy adults and people with atopic dermatitis (eczema). It aims to see if the drug is safe and how the body processes it. If you have moderate to severe eczema that started at least a year ago, you may be able to join the patient part of the study.
Hear when a new Atopic Dermatitis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.